Stoke Therapeutics
STOK
STOK
93 hedge funds and large institutions have $2.39B invested in Stoke Therapeutics in 2020 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
93
Holders Change
+5
Holders Change %
+5.68%
% of All Funds
1.65%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
16
Increased
32
Reduced
25
Closed
11
Calls
$4.78M
Puts
$507K
Net Calls
+$4.27M
Net Calls Change
+$2.79M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$103M |
| 2 |
Goldman Sachs
New York
|
+$29M |
| 3 |
BlackRock
New York
|
+$26.2M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$23.5M |
| 5 |
ALSV
ATP Life Science Ventures
New York
|
+$23.2M |
Top Sellers
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$6.19M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$4.65M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
-$4.34M |
| 4 |
Aviva
London,
United Kingdom
|
-$1.84M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.83M |
